Literature DB >> 32484855

Apolipoprotein A-I enhances activated protein C cytoprotective activity.

Eimear M Gleeson1, Aisling M Rehill2, Orla Willis Fox2, Fionnuala Ni Ainle3, Cormac J McDonnell2, Hannah J Rushe2, Seán McCluskey2, James S O'Donnell1,2,4, Roger J S Preston1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32484855      PMCID： PMC7284090          DOI： 10.1182/bloodadvances.2019001316

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  20 in total

1.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 2.  The Immunoregulatory Activities of Activated Protein C in Inflammatory Disease.

Authors:  Cormac J McDonnell; Erin E Soule; Patrick T Walsh; James S O'Donnell; Roger J S Preston
Journal:  Semin Thromb Hemost       Date:  2017-12-12       Impact factor: 4.180

3.  A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling.

Authors:  E M Gleeson; C J McDonnell; E E Soule; O Willis Fox; H Rushe; A Rehill; O P Smith; J S O'Donnell; R J S Preston
Journal:  J Thromb Haemost       Date:  2017-09-21       Impact factor: 5.824

4.  Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.

Authors:  Laurent O Mosnier; Ranjeet K Sinha; Laurent Burnier; Eveline A Bouwens; John H Griffin
Journal:  Blood       Date:  2012-11-13       Impact factor: 22.113

5.  Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury.

Authors:  Eimear M Gleeson; María G Dichiara; Agustina Salicio; Louise M Quinn; Clive Drakeford; Shane E Russell; Patrick T Walsh; Josune Orbe; José Hermida; Owen P Smith; James S O'Donnell; Ramón Montes; Roger J S Preston
Journal:  Blood       Date:  2015-06-17       Impact factor: 22.113

6.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Authors:  Clemens Feistritzer; Matthias Riewald
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

7.  Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice.

Authors:  Edward Kerschen; Irene Hernandez; Mark Zogg; Shuang Jia; Martin J Hessner; Jose A Fernandez; John H Griffin; Claudia S Huettner; Francis J Castellino; Hartmut Weiler
Journal:  J Clin Invest       Date:  2010-08-16       Impact factor: 14.808

8.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

9.  Activation of endothelial cell protease activated receptor 1 by the protein C pathway.

Authors:  Matthias Riewald; Ramona J Petrovan; Aaron Donner; Barbara M Mueller; Wolfram Ruf
Journal:  Science       Date:  2002-06-07       Impact factor: 47.728

10.  PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.

Authors:  Ranjeet K Sinha; Yaoming Wang; Zhen Zhao; Xiao Xu; Laurent Burnier; Naveen Gupta; José A Fernández; Greg Martin; Sergey Kupriyanov; Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2018-01-17       Impact factor: 25.476
View more
  2 in total

Review 1.  APOA1: a Protein with Multiple Therapeutic Functions.

Authors:  Blake J Cochran; Kwok-Leung Ong; Bikash Manandhar; Kerry-Anne Rye
Journal:  Curr Atheroscler Rep       Date:  2021-02-16       Impact factor: 5.113

2.  Do Circulating Histones Represent the Missing Link among COVID-19 Infection and Multiorgan Injuries, Microvascular Coagulopathy and Systemic Hyperinflammation?

Authors:  Daniela Ligi; Rosanna Maniscalco; Mario Plebani; Giuseppe Lippi; Ferdinando Mannello
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.